NCT04173013No Longer Available不适用
Expanded Access Program Using Uromune for Patients With Recurrent Urinary Tract Infections (rUTI)
Impatients N.V. trading as myTomorrows15 个研究点 分布在 15 个国家开始时间: 2019年11月21日最近更新:
适应症
试验速览
- 阶段
- 不适用
- 状态
- No Longer Available
- 发起方
- 试验地点
- 15
研究概览
简要总结
An Expanded Access Program for UROMUNE® for patients suffering from recurrent/chronic urinary tract infections of diverse etiology. This is for individuals for whom antibiotic therapy has failed, but of consideration in all cases, taking into account antibiotic-induced adverse reactions and increasing antibiotic resistance.
详细描述
UROMUNE® is a mucosal immunotherapy indicated for the prevention of urinary tract infections caused by different pathogens. It works by stimulating the immune system, thus increasing the resistance against recurrent infections. The active substances are 4 inactivated and selected bacterial strains:
- Klebsiella pneumoniae 25%
- Escherichia coli 25%
- Enterococcus faecalis 25%
- Proteus vulgaris 25%
研究设计
- 研究类型
- Expanded Access
入排标准
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Patients suffering recurrent urinary tract infections of diverse etiology.
排除标准
- •Individuals being allergic to any of the ingredients of UROMUNE®.
- •Pregnancy and breast feeding. There are neither specific studies nor a formal contraindication, the physician should value benefits/risk.
研究者
研究点 (15)
Loading locations...
相似试验
No Longer Available
不适用
Expanded Access to TAK-113 for Adults With Metastatic Colorectal Cancer (mCRC)Colorectal CancerNCT06195514Takeda
Approved For Marketing
不适用
A Multicenter Expanded Access Treatment Protocol of Lurbinectedin in Previously Treated SCLC in the USASmall Cell Lung CancerNCT04291937Jazz Pharmaceuticals
No Longer Available
不适用
Expanded Access for the Prevention of Acute Attacks of 1) Hereditary Angioedema (HAE) in Children and 2) Non-histaminergic Angioedema With Normal C1-Inhibitor (C1-INH) in Teenagers and AdultsAngioedemaHereditary Angioedema (HAE)NCT04583007Shire
Temporarily Not Available
不适用
Expanded Access Treatment with [Lu-177]-PNT2002 for Adult Patients with Prostate-Specific Membrane Antigen (PSMA)-Positive Metastatic Castration-Resistant Prostate Cancer (mCRPC)Castration-Resistant Prostatic CancerNCT06033001Lantheus Medical Imaging
No Longer Available
不适用
Expanded Access to Rovalpituzumab TesirineSmall Cell Lung CancerNCT03503890AbbVie